Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrated Brand Solutions (IBS) is a specialized healthcare communications agency providing strategic marketing and branding services to the pharmaceutical and biotechnology sectors. Founded in 1999, the company offers a range of services including brand development, creative execution, and multi-channel commercialization strategies. IBS is recognized for its expertise in translating complex clinical and scientific information into impactful messaging for healthcare providers and patient populations. The firm supports life science clients throughout the product lifecycle, from early-stage market preparation to post-launch brand management. In 2013, IBS was acquired by Cello Health, expanding its global reach and service capabilities. Following the formation of Lumanity in 2022, the agency's operations were integrated into a broader suite of commercialization and market access solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrated Brand Solutions.